Braeburn focuses on the development and commercialization of medications for the treatment of central nervous system disorders... Read more
Braeburn Pharmaceuticals, Inc. President & CEO: Michael M. Derkacz

President & CEO

Michael M. Derkacz

CEO Approval Rating

67/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?
Funding
$110M
Investments
1

Braeburn Pharmaceuticals, Inc. Competitors

1Minerva Neurosciences
2Adamas
3Zogenix
4Cynapsus
5Sage Therapeutics
6Voyager
7Neurona
8Nanna Therapeutics
9Mitochon
10Indivior

Trending Companies